Back to top
more

Insmed (INSM)

(Delayed Data from NSDQ)

$25.81 USD

25.81
2,740,799

+0.54 (2.14%)

Updated Apr 24, 2024 04:00 PM ET

After-Market: $25.81 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value D Growth A Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 31% (78 out of 252)

Industry: Medical - Biomedical and Genetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for INSM

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for Insmed, Inc falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 780 1,148 717 533 487
Receivables 41 30 24 17 19
Notes Receivable 0 0 0 0 0
Inventories 83 70 67 50 28
Other Current Assets 24 25 29 24 20
Total Current Assets 929 1,273 837 623 555
Net Property & Equipment 65 56 53 54 60
Investments & Advances 0 0 50 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 200 205 210 49 54
Deposits & Other Assets 97 76 51 27 20
Total Assets 1,330 1,656 1,244 796 742
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 0 0 0 0 0
Accounts Payable 215 182 36 43 13
Current Portion Long-Term Debt 0 0 0 0 0
Current Portion Capital Leases 3 1 1 1 1
Accrued Expenses 0 0 89 63 60
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 0 0 0 0 0
Total Current Liabilities 226 190 135 119 85
Mortgages 0 0 0 0 0
Deferred Taxes/Income 0 0 0 0 0
Convertible Debt 0 0 0 0 0
Long-Term Debt 1,155 1,125 567 356 336
Non-Current Capital Leases 27 30 14 15 20
Other Non-Current Liabilities 243 209 96 9 11
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 1,662 1,568 833 520 481
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 1 1 1 1 1
Capital Surplus 3,113 2,782 2,674 2,105 1,797
Retained Earnings -3,446 -2,697 -2,265 -1,831 -1,537
Other Equity -1 1 1 0 0
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity -332 88 410 276 262
Total Liabilities & Shareholder's Equity 1,330 1,656 1,244 796 742
Total Common Equity -332 88 410 276 262
Shares Outstanding 143.00 135.40 118.30 101.80 89.30
Book Value Per Share -2.32 0.65 3.47 2.71 2.93

Fiscal Year End for Insmed, Inc falls in the month of December.

All items in Millions except Per Share data.

3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Assets          
Cash & Equivalents -99,999 780 786 918 999
Receivables NA 41 36 31 31
Notes Receivable NA 0 0 0 0
Inventories NA 83 78 77 71
Other Current Assets NA 24 27 26 29
Total Current Assets NA 929 927 1,052 1,129
Net Property & Equipment NA 65 65 62 60
Investments & Advances NA 0 0 0 0
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 0 0 0 0
Intangibles NA 200 201 202 204
Deposits & Other Assets NA 97 92 83 81
Total Assets NA 1,330 1,325 1,439 1,518
Liabilities & Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Notes Payable NA 0 0 0 0
Accounts Payable NA 215 188 198 179
Current Portion Long-Term Debt NA 0 0 0 0
Current Portion Capital Leases NA 3 3 2 2
Accrued Expenses NA 0 0 0 0
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities NA 0 0 0 0
Total Current Liabilities NA 226 197 204 188
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 0 0 0 0
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 1,155 1,148 1,140 1,132
Non-Current Capital Leases NA 27 28 28 29
Other Non-Current Liabilities NA 229 210 199
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 1,662 1,614 1,595 1,562
Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 1 1 1 1
Capital Surplus NA 3,113 2,971 2,945 2,809
Retained Earnings NA -3,446 -3,260 -3,101 -2,856
Other Equity NA -1 -2 -1 1
Treasury Stock NA 0 0 0 0
Total Shareholder's Equity NA -332 -289 -156 -45
Total Liabilities & Shareholder's Equity NA 1,330 1,325 1,439 1,518
Total Common Equity 0 -332 -289 -156 -45
Shares Outstanding 148.50 143.00 143.00 136.40 136.40
Book Value Per Share 0.00 -2.32 -2.02 -1.14 -0.33